An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...

A U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...

The prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

A “game-changing” Ozempic-style daily pill could transform public health in Britain, experts have said. The drug is expected ...

HANOI, VIETNAM – Media OutReach Neswire – 14 April 2025 – Together with world-renowned scientists including Prof. Joel F.

Beyond diabetes 2024 was a landmark year for GLP-1 research ... He elaborated, "We have trials underway for Alzheimer's disease with oral semaglutide, which are expected to conclude by the end of 2025 ...

HANOI, VIETNAM - Media OutReach Neswire - 14 April 2025 - Together with world-renowned scientists including Prof. Joel F.

Not Just For Blood Sugar! Oral Semaglutide Shown To Cut Heart Risk In Type 2 Diabetes (Image Credits: iStock) Novo Nordisk has released the full results of its landmark SOUL clinical trial, confirming ...

The Colosseum was Italy’s most-visited landmark, attracting over 12 million travelers in 2023 alone, according to AP. "The investigation was launched in July 2023, after the Authority gathered ...